mRNA |
KU-55933 |
CTRPv2 |
pan-cancer |
AAC |
-0.035 |
0.3 |
mRNA |
Dasatinib |
GDSC1000 |
pan-cancer |
AAC |
0.047 |
0.3 |
mRNA |
RO4929097 |
CTRPv2 |
pan-cancer |
AAC |
-0.051 |
0.3 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.3 |
mRNA |
N9-isopropylolomoucine |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.3 |
mRNA |
BRD-K28456706 |
CTRPv2 |
pan-cancer |
AAC |
-0.035 |
0.3 |
mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.3 |
mRNA |
Rapamycin |
GDSC1000 |
pan-cancer |
AAC |
0.046 |
0.3 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.3 |
mRNA |
OSI-906 |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.3 |